| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RILPL2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | IPMK | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | MGME1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | POLE3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | SMIM6 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | AL365181.1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ZNF582 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | SRF | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | SF3B6 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | NCOA1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
